About Index Trending news
Lists
Pricing
Verastem

Verastem

Verastem

Verastem is a biopharmaceutical company focused on discovering and developing novel drugs that selectively target cancer stem cells.

Elsewhere

Alexa global traffic share

Latest funding Show all
Venture capital (Series C)
$20,000,000
Employees

Team size

10+
Locations
HQ
Xconomy

Verastem Takes a Low-Cost Flier on Infinity’s Blood Cancer Drug

Health Science
Xconomy

Verastem Sinks as Mesothelioma Study Halted For Futility

Health